New Method to Close Nasal Septal Perforation

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-58
SponsorHelwan University

About this trial

The goal of this clinical trial is to investigate if a 3-dimensional fabricated nasal mesh works to close nasal septal perforations. Under general anesthesia, during nasal septal perforation repair surgery, the investigator will place the mesh between the elevated mucoperichondrial flaps opposite the site of the perforation and confirm its original position at both sides under nasal endoscope. Endoscopic examination for septal mucosa status will be done monthly for a three months follow up period.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients undergoing nasal septal perforation repair surgery.

Disqualifiers

Patients with known allergy to polycaprolactone.

Pregnancy or lactation.

Trial design

Design model

Single group

Treatments tested in this trial

  • Polycaprolactone nasal mesh

    Device

    a 3-dimensional fabricated Polycaprolactone nasal mesh

Treatment groups

23 Participants
are divided into 1 treatment group
Group A: Polycaprolactone nasal meshExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Mean Change in Post-operative healing of septal perforation

Endoscopic evaluation of nasal septal mucosa status will be classified as complete bilateral healing, complete unilateral healing, no healing, and perforation.

Time frame
for a three months follow up period

Secondary outcomes

1

Postoperative complications

The following complications will be evaluated on a present/absent basis:hematoma-infection-allergy

Time frame
for a three months follow up period

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.